SOPHiA GENETICS (SOPH) Non-Current Deferred Tax Liability (2020 - 2021)
SOPHiA GENETICS (SOPH) reported Non-Current Deferred Tax Liability of $646000.0 for Q4 2021, up 101.25% on a YoY basis from $321000.0 in Q4 2020, and up 101.25% sequentially from $321000.0 in Q4 2020.
SOPHiA GENETICS (SOPH) Non-Current Deferred Tax Liability (2020 - 2021) Analysis & Trends
SOPHiA GENETICS (SOPH) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $646000.0 in Q4 2021.
- For the quarter ending Q4 2021, Non-Current Deferred Tax Liability rose 101.25% year-over-year to $646000.0; the trailing twelve-month figure through Dec 2021 stood at $646000.0 (up 101.25% YoY), and the FY2021 full-year result was $646000.0, up 101.25% from the prior year.
- Non-Current Deferred Tax Liability rose to $646000.0 in Q4 2021, from $321000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $646000.0 in Q4 2021 to a low of $321000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.98 Bn | 23.66 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 15.01 Bn | 14.11 Bn | 482.22 Mn |
| 3 | Healthequity | 8.09 Bn | 7.83 Bn | 256.31 Mn |
| 4 | 10x Genomics | 5.93 Bn | 5.39 Bn | 106.18 Mn |
| 5 | Hinge Health | 5.90 Bn | 5.58 Bn | 154.23 Mn |
| 6 | Waystar Holding | 4.45 Bn | 4.38 Bn | 216.84 Mn |
| 7 | MiniMed | 4.35 Bn | 4.06 Bn | 480.00 Mn |
| 8 | Doximity | 3.88 Bn | 3.13 Bn | 125.97 Mn |
| 9 | Privia Health | 3.20 Bn | 2.78 Bn | - |
| 10 | SOPHiA GENETICS | 385.65 Mn | 315.36 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 646,000.00 |
| Dec 31, 2021 | 646,000.00 |
| Dec 31, 2020 | 321,000.00 |
| Dec 31, 2020 | 321,000.00 |